EXTERNAL COLLABORATORS

Professor Tobias Bast

Professor Tobias Bast

Associate Professor at University of Nottingham.
Novel animal model of Alzheimer’s (T30).
Professor Isabel Bermúdez-Diaz

Professor Isabel Bermúdez-Diaz

Professor of Neuropharmacology at Oxford Brookes University.
Target engagement: characterisation of the binding of the peptide and drugs on the alpha7 nicotinic receptor.
Dr Steven Cobb

Dr Steven Cobb

Associate Professor in Chemical-Biology and Director of the Centre for Global Infectious Diseases at Durham University.
Drug discovery: peptoid and peptide chemistry to tackle interesting and challenging biological problems. He is a valued member of our Drug Risk Task Force.
Dr Gregory Cole

Dr Gregory Cole

Professor of Medicine and Neurology at University of California, Los Angeles
Alzheimer’s: Proof of concept and characterisation of NBP14 in pathology
Professor Stephanie Cragg

Professor Stephanie Cragg

Professor of Neuroscience at University of Oxford
Parkinson’s: Effects of T30 and NBP14 on dopamine release ex vivo.
Professor María-Salud García Ayllón

Professor María-Salud García Ayllón

Principal Investigator at Universidad Miguel Hernández de Elche
Proof of concept: Comparison of rat embryo brains with pathology
Andrea Malaspina

Andrea Malaspina

Clinical Senior Lecturer in Neurology at Queens Mary, University of London
ALS: Relation of plasma T14 to pathology.
Professor Javier Saez-Valero

Professor Javier Saez-Valero

Principal Investigator at Universidad Miguel Hernández de Elche
Proof of concept: Comparison of rat embryo brains with AD pathology.
Professor Tennore Ramesh

Professor Tennore Ramesh

Non-Clinical Lecturer at Sheffield University
ALS: Effects of T30 and NBP14 in zebrafish model.
Neuro-Bio Ltd
Building F5
Culham Science Centre
Abingdon
Oxfordshire
OX14 3DB
United Kingdom

(+44) 01235 420085

info@neuro-bio.com

© All Rights Reserved NeuroBio